123 related articles for article (PubMed ID: 1369022)
21. HPMA copolymer conjugates with reduced anti-CD20 antibody for cell-specific drug targeting. I. Synthesis and in vitro evaluation of binding efficacy and cytostatic activity.
Etrych T; Strohalm J; Kovár L; Kabesová M; Ríhová B; Ulbrich K
J Control Release; 2009 Nov; 140(1):18-26. PubMed ID: 19632282
[TBL] [Abstract][Full Text] [Related]
22. Synthesis of elastic biodegradable polyesters of ethylene glycol and butylene glycol from sebacic acid.
Park HS; Seo JA; Lee HY; Kim HW; Wall IB; Gong MS; Knowles JC
Acta Biomater; 2012 Aug; 8(8):2911-8. PubMed ID: 22522011
[TBL] [Abstract][Full Text] [Related]
23. In vitro bone biocompatibility of poly (anhydride-co-imides) containing pyromellitylimidoalanine.
Attawia MA; Uhrich KE; Botchwey E; Langer R; Laurencin CT
J Orthop Res; 1996 May; 14(3):445-54. PubMed ID: 8676258
[TBL] [Abstract][Full Text] [Related]
24. Biodegradable poly(ester-anhydride) for new antifouling coating.
Faÿ F; Linossier I; Langlois V; Vallée-Rehel K
Biomacromolecules; 2007 May; 8(5):1751-8. PubMed ID: 17425364
[No Abstract] [Full Text] [Related]
25. Synthetic, implantable polymers for IUdR radiosensitization of experimental human malignant glioma.
Yuan X; Dillehay LE; Williams JR; Williams JA
Cancer Biother Radiopharm; 1999 Jun; 14(3):187-202. PubMed ID: 10850303
[TBL] [Abstract][Full Text] [Related]
26. Controlled delivery systems for proteins using polyanhydride microspheres.
Tabata Y; Gutta S; Langer R
Pharm Res; 1993 Apr; 10(4):487-96. PubMed ID: 8483830
[TBL] [Abstract][Full Text] [Related]
27. Poly(ethylene glycol)-poly(ester-carbonate) block copolymers carrying PEG-peptidyl-doxorubicin pendant side chains: synthesis and evaluation as anticancer conjugates.
Andersson L; Davies J; Duncan R; Ferruti P; Ford J; Kneller S; Mendichi R; Pasut G; Schiavon O; Summerford C; Tirk A; Veronese FM; Vincenzi V; Wu G
Biomacromolecules; 2005; 6(2):914-26. PubMed ID: 15762660
[TBL] [Abstract][Full Text] [Related]
28. In vitro release and antibacterial activity of poly (oleic/linoleic acid dimer: sebacic acid)-gentamicin.
Yang XF; Zeng FD; Zhou ZB; Huang KX; Xu HB
Acta Pharmacol Sin; 2003 Apr; 24(4):306-10. PubMed ID: 12676068
[TBL] [Abstract][Full Text] [Related]
29. Mechanistic relationships between polymer microstructure and drug release kinetics in bioerodible polyanhydrides.
Shen E; Kipper MJ; Dziadul B; Lim MK; Narasimhan B
J Control Release; 2002 Jul; 82(1):115-25. PubMed ID: 12106982
[TBL] [Abstract][Full Text] [Related]
30. A microfabrication method of a biodegradable polymer chip for a controlled release system.
Ito Y; Hasuda H; Morimatsu M; Takagi N; Hirai Y
J Biomater Sci Polym Ed; 2005; 16(8):949-55. PubMed ID: 16128230
[TBL] [Abstract][Full Text] [Related]
31. Molecular weight changes in polymer erosion.
D'Emanuele A; Hill J; Tamada JA; Domb AJ; Langer R
Pharm Res; 1992 Oct; 9(10):1279-83. PubMed ID: 1448426
[TBL] [Abstract][Full Text] [Related]
32. Controlled protein delivery from biodegradable tyrosine-containing poly(anhydride-co-imide) microspheres.
Chiba M; Hanes J; Langer R
Biomaterials; 1997 Jul; 18(13):893-901. PubMed ID: 9199758
[TBL] [Abstract][Full Text] [Related]
33. Design of a core-shelled polymer cylinder for potential programmable drug delivery.
Qiu LY; Zhu KJ
Int J Pharm; 2001 May; 219(1-2):151-60. PubMed ID: 11337175
[TBL] [Abstract][Full Text] [Related]
34. Poly(ortho ester) biodegradable polymer systems.
Heller J; Himmelstein KJ
Methods Enzymol; 1985; 112():422-36. PubMed ID: 3930918
[TBL] [Abstract][Full Text] [Related]
35. Phase behavior and miscibility in blends of poly(sebacic anhydride)/poly(ethylene glycol).
Chan CK; Chu IM
Biomaterials; 2002 Jun; 23(11):2353-8. PubMed ID: 12013182
[TBL] [Abstract][Full Text] [Related]
36. Interferon-containing controlled-release polymers for localized cerebral immunotherapy.
Wiranowska M; Ransohoff J; Weingart JD; Phelps C; Phuphanich S; Brem H
J Interferon Cytokine Res; 1998 Jun; 18(6):377-85. PubMed ID: 9660244
[TBL] [Abstract][Full Text] [Related]
37. Biodegradable polymers for ocular drug delivery.
Kimura H; Ogura Y
Ophthalmologica; 2001; 215(3):143-55. PubMed ID: 11340382
[TBL] [Abstract][Full Text] [Related]
38. The effect of storage temperatures on the in vitro properties of a polyanhydride implant containing gentamicin.
Tian Y; Li L; Gao X; Deng J; Stephens D; Robinson D; Chang H
Drug Dev Ind Pharm; 2002 Sep; 28(8):897-903. PubMed ID: 12378959
[TBL] [Abstract][Full Text] [Related]
39. Crosslinked polyanhydrides for use in orthopedic applications: degradation behavior and mechanics.
Muggli DS; Burkoth AK; Anseth KS
J Biomed Mater Res; 1999 Aug; 46(2):271-8. PubMed ID: 10380006
[TBL] [Abstract][Full Text] [Related]
40. Branched biodegradable polyesters for parenteral drug delivery systems.
Breitenbach A; Li YX; Kissel T
J Control Release; 2000 Feb; 64(1-3):167-78. PubMed ID: 10640655
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
